Stay updated on Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page.
Latest updates to the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.6%
- Check14 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference3%
- Check22 days agoChange DetectedDifference0.5%
- Check29 days agoChange DetectedSeveral key genetic and rare disease resources have been removed from the website, including links to conditions like Leigh syndrome and pontocerebellar hypoplasia, which may impact access to important health information.SummaryDifference5%
- Check36 days agoChange DetectedNew resources have been added related to genetic conditions, including specific pages for pontocerebellar hypoplasia and Leigh syndrome, as well as links to various health and research organizations.SummaryDifference0.8%
- Check43 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference5%
Stay in the know with updates to Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page.